Table 4.
TNF-α | IL-6 | IL-8 | IFG | CRP | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Parameter | Estimate | SE | Estimate | SE | Estimate | SE | Estimate | SE | Estimate | SE |
Intercept | 0.728*** | 0.029 | −0.007 | 0.058 | 0.712*** | 0.037 | 0.034 | 0.069 | 0.170 | 0.094 |
Time | 0.011 | 0.008 | 0.036* | 0.016 | −0.027* | 0.011 | −0.108*** | 0.021 | 0.045 | 0.027 |
Age baseline | 0.005** | 0.001 | 0.005 | 0.003 | 0.001 | 0.002 | <0.001 | 0.003 | 0.003 | 0.005 |
Female gender | 0.020 | 0.024 | 0.038 | 0.053 | 0.064* | 0.029 | 0.184** | 0.055 | 0.072 | 0.082 |
Education | < −0.001 | 0.003 | −0.006 | 0.008 | −0.003 | 0.004 | 0.002 | 0.008 | −0.011 | 0.012 |
Years caregiving | −0.003 | 0.003 | 0.002 | 0.007 | 0.002 | 0.003 | 0.006 | 0.007 | 0.016 | 0.010 |
Spouse placed | −0.001 | 0.026 | −0.047 | 0.050 | −0.059 | 0.033 | −0.043 | 0.063 | 0.016 | 0.082 |
Spouse deceased | −0.008 | 0.032 | 0.011 | 0.061 | −0.064 | 0.041 | −0.063 | 0.078 | −0.119 | 0.100 |
CVD | 0.009 | 0.024 | 0.010 | 0.048 | −0.013 | 0.031 | −0.020 | 0.059 | −0.029 | 0.079 |
Diabetes | 0.016 | 0.030 | −0.061 | 0.062 | 0.097* | 0.038 | 0.074 | 0.071 | −0.054 | 0.099 |
Aspirin | −0.008 | 0.020 | −0.045 | 0.038 | 0.006 | 0.027 | −0.034 | 0.049 | −0.015 | 0.062 |
Cholesterol drug | 0.036 | 0.020 | 0.031 | 0.041 | 0.037 | 0.025 | 0.035 | 0.047 | −0.089 | 0.066 |
Antidepressant drug | 0.015 | 0.021 | 0.001 | 0.044 | 0.030 | 0.027 | 0.029 | 0.052 | 0.122 | 0.070 |
Mean arterial pressure | <0.001 | 0.001 | <0.001 | 0.002 | −0.001 | 0.001 | < −0.001 | 0.002 | −0.001 | 0.003 |
Body mass index | −0.001 | 0.002 | 0.009 | 0.005 | −0.004 | 0.003 | −0.009 | 0.005 | 0.016* | 0.007 |
LDL-C:HDL-C | 0.021 | 0.014 | 0.020 | 0.028 | 0.027 | 0.017 | −0.022 | 0.033 | 0.066 | 0.045 |
Ever smoker | 0.019 | 0.020 | 0.078 | 0.044 | 0.036 | 0.025 | −0.017 | 0.048 | 0.023 | 0.068 |
Physical activity | 0.002 | 0.006 | −0.007 | 0.012 | −0.008 | 0.008 | −0.013 | 0.015 | −0.027 | 0.019 |
Alcohol consumption | 0.001 | 0.002 | 0.001 | 0.003 | 0.003 | 0.002 | 0.004 | 0.004 | −0.002 | 0.005 |
PSQI | 0.003 | 0.003 | 0.007 | 0.006 | 0.006 | 0.004 | 0.005 | 0.007 | −0.006 | 0.009 |
ADL/IADL | −0.004 | 0.002 | −0.008 | 0.004 | −0.007* | 0.003 | −0.005 | 0.005 | −0.006 | 0.007 |
Depressive symptoms | −0.001 | 0.002 | 0.003 | 0.004 | −0.007** | 0.002 | −0.001 | 0.005 | 0.004 | 0.006 |
Total leisure satisfaction | −0.002* | 0.001 | −0.001 | 0.002 | −0.004*** | 0.001 | −0.004* | 0.002 | < −0.001 | 0.002 |
Notes. ADL/IADL = total activities of daily living/instrumental ADL requiring help; CRP = C-reactive protein; CVD = cardiovascular disease; HDL-C = high-density lipoprotein cholesterol; IL-6 = interleukin-6; IL-8 = interleukin-8; IFG = Interferon-γ; LDL-C = low-density lipoprotein cholesterol; PSQI = Pittsburgh Sleep Quality Index; TNF-α = tumor necrosis factor-α.
All independent variables were centered to the mean such that the intercepts show the mean biomarker concentrations in the entire sample. Categorical variables were contrast coded as female gender (+0.5) vs. male gender (−0.5), CVD (+0.5) vs. no CVD (−0.5), diabetes (+0.5) vs. no diabetes (−0.5), medications (+0.5) vs. no medications (−0.5), ever smoker (+0.5) vs. never smoker (−0.5), and caregiver (+0.5) vs. noncaregiver (−0.5). “Placed spouse” and “spouse deceased” indicate the immediate change in the biomarker concentration assessed 3 months after the respective transition. “Time” indicates the change in the biomarker concentration per each assessment the participant was in the study.
Data are given as log-transformed slopes (SE): *p < .05. **p < .01. ***p < .001.